News

October 9, 2018

Glympse Bio, Inc. Raises $22m Series A Financing

Read more
October 2, 2018

Akselos raised $10 million financing from Innogy Ventures & Shell Ventures

Read more
March 6, 2018

From Idea to Impact

By empowering MIT’s researchers to make a difference in the world,the Deshpande Center

Read more
July 13, 2016

TARIS Biomedical® Initiates Phase 1b Clinical Trial of TAR-200 (GemRIS™) in Patients with Muscle-Invasive Bladder Cancer

Deshpande spinout, TARIS Biomedical LLC, announced the initiation of a Phase 1b clinical trial of TAR-200 (GemRIS™) in patients with muscle-invasive bladder cancer (MIBC).

Read more

Pages